J Viral Hepat

1. CONWAY A, Grebely J, Treloar C, Matthews S, et al
   Policymaker Perspectives on the Role of Health Systems in Sustainable Hepatitis C Point-Of-Care Testing in Australia.
   J Viral Hepat. 2025;32:e70080.
   

   >> Share

   
   
2. XIAO J, Zhang X, Mao X, Lai S, et al
   Efficacy and Safety of Velpatasvir Plus Sofosbuvir With or Without Ribavirin in Hepatitis C Patients With Decompensated Cirrhosis: A Systematic Review and Meta-Analysis.
   J Viral Hepat. 2025;32:e70078.
   

   >> Share

   
   
3. LUONG CL, Ellett LK, Pratt N, Staff K, et al
   Trends in Use of Direct-Acting Antivirals for Treatment of Hepatitis C Virus Infection in Australia 2016-2024.
   J Viral Hepat. 2025;32:e70082.
   

   >> Share

   
   

   
   PLoS One

4. HAN L, Bi L, Li X
   The diagnostic value of decreased levels of inflammatory markers for the state of hepatitis C virus (HCV) infection.
   PLoS One. 2025;20:e0332105.
   

   >> Share

   
   
5. WAGI CR, McDowell R, Wright A, Egan KL, et al
   Navigating Hepatitis C care: Knowledge gaps and access barriers among young women who inject drugs in rural Appalachia.
   PLoS One. 2025;20:e0331849.
   

   >> Share

   
   
6. SHENGELAIA L, Anderson EJ, Butsashvili M, Gulbiani L, et al
   Hepatitis C virus reinfection among people who inject drugs in the country of Georgia and injection-related risk factors: Implications for HCV elimination in the EECA region.
   PLoS One. 2025;20:e0330764.
   

   >> Share

   
   

   
   Transfusion

7. HUSEYNOVA E, Haynes J, Notari EP, Custer B, et al
   Incidence and window period residual risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2017 to 2023: The transfusion-transmissible infections monitoring system.
   Transfusion. 2025 Sep 7. doi: 10.1111/trf.18398.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share